ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. The company specialises in high quality medicines for the treatment of important diseases in the livestock sector. ECO Animal Health are dedicated to the research, development and marketing of strong brands, differentiated generics and innovative new solutions.
HY26: momentum accelerates
Eco Animal Health delivers a strong H1 FY26 performance. Revenue surged 19% YoY to £39.4m, ahead of...
Read moreECOVAXXIN® MS EU authorisation paves way for commercial launch
Eco Animal Health reports that the Committee for Medicinal Products for Veterinary Use (CVMP) of...
Read moreFirst half trading significantly stronger
In a statement to accompany yesterday's AGM, Eco Animal Health reports that trading in the first...
Read moreStrong second half boosts FY25
For the year to 31 March 2025 Eco Animal Health reported results in line with the outlook of the...
Read more
Trading update: FY25 EBITDA marginally ahead
In a Trading Update for the year to 31st March, Eco Animal Health reports that, due to strong...
Read more
Milestone poultry vaccine submission
Eco Animal Health reports that it has submitted a key Market Authorisation Application (MAA) to the...
Read more
FY25 interims point to a stronger second half
For the six months to 30 September 2024 ECO Animal Health reported revenue of £33.2m, -13%YoY and...
Read moreTrading update: headwinds in China
In a Trading Update for the six months to 30 September 2024, ECO Animal Health reports reduced...
Read more
- Prev
- 1 of 3 pages
- Next
Register to be first
Get research on the companies that interest you straight to your inbox
